For Life Sciences 

 

Aparito supports the development, access and monitoring of promising therapies for children and patients with rare conditions using innovative data collection technology.

 

We combine in-house expertise in drug development for rare diseases and paediatrics using the most effective regulatory strategies.

 

Data is captured using a choice of wearable technologies and delivered via a digital platform which means that 99.9% of the clinical trial journey will be experienced outside of the clinical environment. Our platform is disease agnostic but our approach is disease specific. By integrating our technology into a drug development programme from the very start, we can:

​

• Create a comprehensive Natural History Study

​

• Create a disease-specific and digitally enabled Patient Reported Outcome instrument to convey patient impact and help assess QoL. 

 

• Map the patient pathway through the healthcare system. 

 

• Keep patients engaged. 

​

For Patients

​

We put the patient experience at the heart of our service design, working closely with patient groups to ensure that our technology fits their needs and is integrated into drug development programmes from the earliest phase. 

 

Aparito supported trials are better for patients:

​

• Mobile apps and wearable devices are tailored to a specific disease. They deliver relevant, real-time data to clinicians for faster diagnosis, treatment and drug development  

​​

• Remote monitoring offers additional features not available through traditional hospital-based research, minimising hospital visits, capturing data on physiological parameters such as heart rate, ambulation, sleep patterns, and other data capture options depending on the disease manifestation

​​

• Remote, decentralised deployment limits the geographical and feasibility impact on patient trial recruitment and reduces the burden on patients and their families.

​